| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hologic Inc (NASDAQ: HOLX)
HOLX Technical Analysis
3
| As on 24th Oct 2025 HOLX STOCK Price closed @ 73.99 and we RECOMMEND Sell for LONG-TERM with Stoploss of 74.10 & Sell for SHORT-TERM with Stoploss of 74.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HOLXSTOCK Price
| Open | 73.91 | Change | Price | % |
| High | 74.11 | 1 Day | 0.10 | 0.14 |
| Low | 73.87 | 1 Week | 6.99 | 10.43 |
| Close | 73.99 | 1 Month | 9.54 | 14.80 |
| Volume | 5163316 | 1 Year | -1.87 | -2.47 |
| 52 Week High 83.72 | 52 Week Low 52.73 | ||||
NASDAQ USA Most Active Stocks
| BYND | 2.19 | -22.89% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| INTC | 38.28 | 0.31% |
| OPEN | 7.97 | 13.37% |
| NVDA | 186.26 | 2.25% |
| LMDX | 0.02 | 0.00% |
| BITF | 4.61 | 10.55% |
| AKTS | 0.04 | 0.00% |
| TSLA | 433.72 | -3.40% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HOLX Daily Charts |
HOLX Intraday Charts |
Whats New @ Bazaartrend |
HOLX Free Analysis |
|
|
HOLX Important Levels Intraday
| RESISTANCE | 74.45 |
| RESISTANCE | 74.30 |
| RESISTANCE | 74.21 |
| RESISTANCE | 74.12 |
| SUPPORT | 73.86 |
| SUPPORT | 73.77 |
| SUPPORT | 73.68 |
| SUPPORT | 73.53 |
HOLX Forecast October 2025
| 4th UP Forecast | 92.91 |
| 3rd UP Forecast | 86.84 |
| 2nd UP Forecast | 83.09 |
| 1st UP Forecast | 79.34 |
| 1st DOWN Forecast | 68.64 |
| 2nd DOWN Forecast | 64.89 |
| 3rd DOWN Forecast | 61.14 |
| 4th DOWN Forecast | 55.07 |
HOLX Weekly Forecast
| 4th UP Forecast | 79.33 |
| 3rd UP Forecast | 77.62 |
| 2nd UP Forecast | 76.56 |
| 1st UP Forecast | 75.50 |
| 1st DOWN Forecast | 72.48 |
| 2nd DOWN Forecast | 71.42 |
| 3rd DOWN Forecast | 70.36 |
| 4th DOWN Forecast | 68.65 |
HOLX Forecast2025
| 4th UP Forecast | 137.14 |
| 3rd UP Forecast | 116.89 |
| 2nd UP Forecast | 104.37 |
| 1st UP Forecast | 91.85 |
| 1st DOWN Forecast | 56.13 |
| 2nd DOWN Forecast | 43.61 |
| 3rd DOWN Forecast | 31.09 |
| 4th DOWN Forecast | 10.84 |
Hologic Inc ( NASDAQ USA Symbol : HOLX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HOLX Business Profile
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts. Address: 250 Campus Drive, Marlborough, MA, United States, 01752
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service